CA2123611A1 - Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-myb - Google Patents

Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-myb

Info

Publication number
CA2123611A1
CA2123611A1 CA002123611A CA2123611A CA2123611A1 CA 2123611 A1 CA2123611 A1 CA 2123611A1 CA 002123611 A CA002123611 A CA 002123611A CA 2123611 A CA2123611 A CA 2123611A CA 2123611 A1 CA2123611 A1 CA 2123611A1
Authority
CA
Canada
Prior art keywords
seq
oligonucleotide
mer
oligodeoxynucleotide
phosphorothioate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002123611A
Other languages
English (en)
Inventor
Alan M. Gewirtz
Bruno Calabretta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Temple University of Commonwealth System of Higher Education
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2123611A1 publication Critical patent/CA2123611A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/312Phosphonates
    • C12N2310/3125Methylphosphonates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002123611A 1991-11-15 1992-11-12 Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-myb Abandoned CA2123611A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79299991A 1991-11-15 1991-11-15
US792,999 1991-11-15
PCT/US1992/009656 WO1993009789A1 (fr) 1991-11-15 1992-11-12 Traitement d'un melanome au moyen d'oligonucleotides anti-codants par rapport au proto-oncogene c-myb

Publications (1)

Publication Number Publication Date
CA2123611A1 true CA2123611A1 (fr) 1993-05-27

Family

ID=25158769

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002123611A Abandoned CA2123611A1 (fr) 1991-11-15 1992-11-12 Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-myb

Country Status (5)

Country Link
EP (1) EP0667778A4 (fr)
JP (1) JPH07501525A (fr)
AU (1) AU3070992A (fr)
CA (1) CA2123611A1 (fr)
WO (1) WO1993009789A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5749847A (en) * 1988-01-21 1998-05-12 Massachusetts Institute Of Technology Delivery of nucleotides into organisms by electroporation
US5989849A (en) * 1991-05-09 1999-11-23 Temple University Of The Commonwealth System Of Higher Education Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods
US5646042A (en) * 1992-08-26 1997-07-08 Ribozyme Pharmaceuticals, Inc. C-myb targeted ribozymes
US5658780A (en) * 1992-12-07 1997-08-19 Ribozyme Pharmaceuticals, Inc. Rel a targeted ribozymes
WO1995011301A1 (fr) * 1993-10-19 1995-04-27 The Regents Of The University Of Michigan Apoptose induite par p53
US5618709A (en) * 1994-01-14 1997-04-08 University Of Pennsylvania Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5994320A (en) * 1995-02-06 1999-11-30 Regents Of The University Of Minnesota Antisense oligonucleotides and methods for treating central nervous system tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof

Also Published As

Publication number Publication date
EP0667778A4 (fr) 1997-04-16
WO1993009789A1 (fr) 1993-05-27
EP0667778A1 (fr) 1995-08-23
AU3070992A (en) 1993-06-15
JPH07501525A (ja) 1995-02-16

Similar Documents

Publication Publication Date Title
US5618709A (en) Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein
US5734039A (en) Antisense oligonucleotides targeting cooperating oncogenes
US5985558A (en) Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
AU641636B2 (en) Antisense oligonucleotides to C-MYB proto-oncogene and uses thereof
JP2003524637A (ja) Lna修飾オリゴヌクレオチドの治療上の使用
ES2326118T3 (es) Regulacion de la expresion del gen bcl-2.
KR20030034153A (ko) Bcl-2 안티센스 올리고머를 이용한 bcl-2 질환의치료 방법
WO1992022303A1 (fr) INHIBITION SELECTIVE DE LA PROLIFERATION DES CELLULES LEUCEMIQUES PAR DES OLIGONUCLEOTIDES ANTI-CODANTS $i(BCR-ABL)
US5635385A (en) Multi-unit ribozyme inhibition of oncogene gene expression
EP0668782B1 (fr) Combinaison d'un agent anti-neoplasique et d'oligonucleotides antisens dans le traitement du cancer
US6015893A (en) Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis
CA2123611A1 (fr) Traitement du melanome avec des oligonucleotides antisens contre le proto-oncogene c-myb
Rubenstein et al. Antisense oligonucleotide intralesional therapy for human PC‐3 prostate tumors carried in athymic nude mice
US5612212A (en) Selective inhibition of cell proliferation by vav antisense oligonucleotides
WO1992020348A1 (fr) Traitement de carcinome colo-rectal a l'aide d'oligonucleotides non codants par rapport au proto-oncogene c-myb
AU646643B2 (en) Antisense oligonucleotides to C-ABL proto-oncogene
WO1994004137A1 (fr) Oligonucleotides non codant complementaires du proto-oncogene de cycline d1
WO1995024223A1 (fr) Inhibition de la proliferation cellulaire par des oligonucleotides non codants specifiques contre e2f-1
WO1998013072A1 (fr) Compositions et procedes destines au traitement de la resistance multiple aux anticancereux
WO1994007538A1 (fr) OLIGONUCLEOTIDES NON CODANTS DU PROTO-ONCOGENE B-m^_y^_b^

Legal Events

Date Code Title Description
FZDE Discontinued